![](/img/cover-not-exists.png)
The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
Al-Keilani, Maha S., Alzoubi, Karem H., Jaradat, Saied A.Volume:
Volume 10
Language:
english
Journal:
Clinical Pharmacology: Advances and Applications
DOI:
10.2147/CPAA.S174074
Date:
October, 2018
File:
PDF, 615 KB
english, 2018